Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Patrys Limited ( (AU:PAB) ) has provided an announcement.
Patrys Limited has announced a change in its registered office and principal place of business to a new address in Melbourne, Australia. This move aligns with the company’s ongoing commitment to developing its innovative deoxymab platform, which has shown promise in targeting cancer cells and addressing inflammatory diseases, potentially transforming treatment landscapes.
More about Patrys Limited
Based in Melbourne, Australia, Patrys Limited is a therapeutic antibody development company focused on its deoxymab platform. These cell-penetrating antibodies target cancer cells by binding to DNA fragments released during cell death, offering potential treatments for various cancers and inflammatory diseases.
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$3.09M
See more data about PAB stock on TipRanks’ Stock Analysis page.